# US 2024/0255580 A1 · Method and control arrangement for mass scale production testing of secondary cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0255580 A1
- Document ID: US20240255580A1
- Status: Published application
- Kind: A1
- Application number: 18/423,536
- Filed: 2024-01-26
- Published: 2024-08-01
- Earliest claimed: 2023-01-26
- Assignees: Northvolt AB
- Applicants: Northvolt AB
- Inventors: Sean Stephenson
- Web page: https://patentgrep.com/patent/US20240255580A1

## CPC

- G01R 31/3865: {related to manufacture, e.g. testing after manufacture}
- G01R 31/3647: {for determining the ability of a battery to perform a critical function, e.g. cranking}
- G01R 31/3648: {comprising digital calculation means, e.g. for performing an algorithm}
- G01R 31/367: Software therefor, e.g. for battery testing using modelling or look-up tables
- G01R 31/392: Determining battery ageing or deterioration, e.g. state of health
- G01R 31/01: Subjecting similar articles in turn to test, e.g. "go/no-go" tests in mass production; Testing objects at points as they pass through a testing station (testing of cables continuously passing the testing apparatus G01R31/59; testing dielectric strength or breakdown voltage G01R31/12)
- Y02E 60/10: Energy storage using batteries
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

The present disclosure pertains to testing of rechargeable cells for use in batteries arranged in electrical vehicles. According to a first aspect the disclosure relates to method for evaluating cell health of secondary cells 1 in mass scale production testing. The method comprises obtaining manufacturing data (i.e. data analysis 41) and generating scanning data by scanning 42 an inside of the secondary cells. The method further comprises determining cell quality using a prediction algorithm, performing additional testing 43 on a selection of the scanned secondary cells and verifying, based on the additional testing, accuracy of the prediction algorithm. The method thereafter comprises evaluating cell health of the individual cells 1 based on the cell quality determined using the prediction algorithm. The disclosure also relates to a corresponding control arrangement.

## Claims

### Claim 1

A method for evaluating cell health of secondary cells (1) in mass scale production testing, the method comprising:
obtaining (S1) manufacturing data (dman) recorded during cell manufacturing and associated with the secondary cells (1), and
upon the secondary cells (1) being fully assembled,
generating (S2) scanning data (dscan) by scanning an inside of, at least a subset of the secondary cells (1) using a radiation-based scanning technology,
determining (S3) cell quality of the individual secondary cells using a prediction algorithm that predicts cell quality based on obtained manufacturing data (dprod) and/or the generated scanning data (dscan),
performing (S4) additional testing using an alternative testing technology having higher reliability than the radiation-based scanning technology, only on a selection of the scanned secondary cells (1),
verifying (S5), based on the additional testing, that accuracy of the prediction algorithm meets predefined accuracy requirements that must be met in order for the determined cell quality to form a basis for production testing, and
evaluating (S7) cell health of the individual secondary cells (1) based on the cell quality determined using the prediction algorithm.

### Claim 2 (depends on 1)

The method of claim 1, wherein the prediction algorithm comprises one or more of:
criteria applicable to identify, based on the scanning data, internal changes in secondary cells associated with cell degradation and/or different types of errors, and
criteria applicable to detect, based on the manufacturing data (dman), potential manufacturing deviations associated with cell degradation and/or different types of errors.

### Claim 3 (depends on 2)

The method of claim 2, wherein the obtained manufacturing data (dman) comprises data collected during Formation and Ageing, F&A, slurry production and/or during electrode coating.

### Claim 4 (depends on 1)

The method of claim 1, wherein the scanning is performed a predetermined time after cells (1) being fully formatted.

### Claim 5 (depends on 1)

The method of claim 1, wherein the scanning is performed by a scanner (51) arranged at a production line.

### Claim 6 (depends on 5)

The method according to claim 5, wherein cells (1) selected to undergo additional testing are side streamed on another line, different from the production line.

### Claim 7 (depends on 1)

The method of claim 1, wherein the selection of secondary cells (1) selected for additional testing comprises:
high performing cells having scanning data (dscan) exceeding an acceptance level for passing with a certain margin, and/or
outliers having scanning data (dscan) within a risk interval just above the acceptance level for passing,
failing cells having scanning data (dscan) failing to meet the acceptance level for passing with a certain margin, and
suspicious cells having deviating manufacturing data (dman).

### Claim 8 (depends on 1)

The method of claim 1, wherein the verifying (S5) comprises comparing determined cell quality with cell quality determined based on the additional testing.

### Claim 9 (depends on 1)

The method of claim 1, wherein the method further comprises:
updating (S8) the prediction algorithm based on cell quality.

### Claim 10 (depends on 1)

The method of claim 1, wherein the verifying (S5) comprises investigating consequences of deviations in the obtained (S1) manufacturing data.

### Claim 11 (depends on 1)

The method of claim 1, wherein the radiation-based scanning technology comprises sound, such as ultrasound or echo sound.

### Claim 12 (depends on 1)

The method of claim 1, further comprising:
developing (S0) the prediction algorithm based on results from additional testing of secondary cells of different cell quality.

### Claim 13 (depends on 1)

The method of claim 1, wherein the additional testing comprises one or more of; cell cycling, short circuit testing, over charging testing, nail penetration testing, thermal testing, or CT-scanning.

### Claim 14 (depends on 1)

A control arrangement (10) configured to perform the method according to claim 1.
